WINNERS & LOSERS: Animalcare agrees to bid; Alumasc lowers forecast
16th Apr 2026 12:02
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday. Read More
| Price | 245.00p on 22-04-2026 at 12:30:09 |
|---|---|
| Change | -5.00p -2% |
| Buy | 250.00p |
| Sell | 240.00p |
| Last Trade: | Sell 1,470.00 at 241.77p |
| Day's Volume: | 21,212 |
| Last Close: | 250.00p |
| Open: | 250.00p |
| ISIN: | GB0000280353 |
| Day's Range | 245.00p - 250.00p |
| 52wk Range: | 207.50p - 395.00p |
| Market Capitalisation: | £88.10m |
| VWAP: | 246.37328p |
| Shares in Issue: | 35.96m |
Sector: Construction
Listed In: FTSE AIM All-Share,
Alumasc Group (ALU) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 1,470 | 241.77p | Ordinary |
13:26:59 - 22-Apr-26 |
| Buy* | 3,659 | 247.188p | Ordinary |
12:45:58 - 22-Apr-26 |
| Buy* | 3,000 | 247.00p | Ordinary |
10:55:03 - 22-Apr-26 |
| Buy* | 249 | 247.40p | Ordinary |
10:44:32 - 22-Apr-26 |
| Sell* | 567 | 241.50p | Ordinary |
10:44:32 - 22-Apr-26 |
| Sell* | 13 | 241.50p | Ordinary |
10:27:42 - 22-Apr-26 |
| Buy* | 1,212 | 247.50p | Ordinary |
10:12:21 - 22-Apr-26 |
| Sell* | 878 | 242.20p | Ordinary |
10:07:31 - 22-Apr-26 |
| Sell* | 1,500 | 245.00p | Ordinary |
10:06:18 - 22-Apr-26 |
| Sell* | 500 | 245.00p | Ordinary |
10:05:36 - 22-Apr-26 |
Alumasc Group (ALU) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 21st Apr 2026 7:00 am | RNS | Director Dealings |
| 20th Apr 2026 2:37 pm | RNS | Holding(s) in Company |
| 16th Apr 2026 7:00 am | RNS | Q3 Trading Update |
| 1st Apr 2026 7:00 am | RNS | Confirmation of CEO appointment |
| 9th Feb 2026 7:00 am | RNS-R | MelloMonday Investor Webinar |
| 3rd Feb 2026 7:00 am | RNS | Interim Results |
| 15th Jan 2026 7:00 am | RNS | Directorate change |
| 10th Dec 2025 9:36 am | RNS | Notice of Half Year Results |
| 21st Nov 2025 2:17 pm | RNS | Director/PDMR Shareholding |
| 7th Nov 2025 11:22 am | RNS | Director/PDMR Shareholding |